SML3946
DFPQ
≥98% (HPLC)
别名:
AP-06-202, N4-Cyclohexyl-N2-(3,4-difluorophenyl)-2,4-quinazolinediamine, N4-Cyclohexyl-N2-(3,4-difluorophenyl)quinazoline-2,4-diamine
登录 查看组织和合同定价。
选择尺寸
变更视图
关于此项目
Assay:
≥98% (HPLC)
Form:
powder
Quality Segment
assay
≥98% (HPLC)
form
powder
color
white to beige
solubility
DMSO: 2 mg/mL, clear
storage temp.
2-8°C
Biochem/physiol Actions
Gs-biased, β2 subtype-selective adrenergic receptor (AR) negative allosteric modulator (NAM) that inhibits β-arrestin recruitment, but not Gs coupling to β2AR.
DFPQ is a Gs-biased, β2 subtype-selective adrenergic receptor (AR) negative allosteric modulator (NAM) that inhibits β-arrestin recruitment (IC50 = 600 nM; 30-min DFPQ pretreatment prior to 12-min 1 μM ISO induction), but not Gs coupling to β2AR (30-min 10 μM DFPQ pretreatment prior to 10-min 1 μM ISO-induced cAMP production). DFPQ effectively inhibits agonist-induced β2AR phosphorylation (IC50 = 2.6 μM; 30-min DFPQ pretreatment prior to 10-min 1 μM ISO induction) and internalization (100% inhibition by 30-min 10 μM DFPQ prior to 1h 10 μM ISO) and protects against the functional desensitization of β-agonist-mediated regulation in cell and tissue models with minimal effects on β1AR.
DFPQ is a Gs-biased, β2 subtype-selective adrenergic receptor (AR) negative allosteric modulator (NAM) that inhibits β-arrestin recruitment (IC50 = 600 nM; 30-min DFPQ pretreatment prior to 12-min 1 μM ISO induction), but not Gs coupling to β2AR (30-min 10 μM DFPQ pretreatment prior to 10-min 1 μM ISO-induced cAMP production). DFPQ effectively inhibits agonist-induced β2AR phosphorylation (IC50 = 2.6 μM; 30-min DFPQ pretreatment prior to 10-min 1 μM ISO induction) and internalization (100% inhibition by 30-min 10 μM DFPQ prior to 1h 10 μM ISO) and protects against the functional desensitization of β-agonist-mediated regulation in cell and tissue models with minimal effects on β1AR.
存储类别
11 - Combustible Solids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable